Snowball logo
logo
VIST

Vistin Pharma ASA

NOK 18.10-NOK 0.25Β  (1.36%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
278.6287.7435.4429.1452.3432.2
COGS
96.1199.9233.2150220.3-
Gross Profit
182.5166.8259.7279.1232-
Operating Expenses & Income
Operating Income
33.25(6.096)68.685.392.35-
Total Operating Expenses
242.6293.8366.8343.8359.9-
R&D Expenses
------
Selling General & Admin Expenses
73.4319.8226.194.2218.55-
Earnings from Continuing Operations
Interest Expense
(0.357)(2.14)(2.266)(2.338)(1.96)(11.27)
Interest Income
1.2550.0280.224.8790.39619.14
Income Tax Expense
7.129(1.322)----
Net Income
Net Income
24.95(4.716)45.662.7574.7570.19
Supplemental
EBIT
33.25(6.096)68.685.397.8-
EBITDA
42.968.41278.13101.8120.3122.9
In millions of NOK, except % and values per 1 share